XLS Merck Serono | Key figures € million Q1 – 2014 Q1 – 2013* Change in % * The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 1,421.1 1,482.1 –4.1 Sales 1,374.9 1,388.8 –1.0 Operating result (EBIT) 235.8 170.2 38.5 Margin (% of sales) 17.2 12.3 EBITDA 428.0 408.3 4.8 Margin (% of sales) 31.1 29.4 EBITDA pre one-time items 438.0 437.7 0.1 Margin (% of sales) 31.9 31.5 Business free cash flow 480.0 340.0 41.2 Development of total revenues and sales as well as results of operations In the first quarter of 2014, total revenues of the Merck Serono division grew organically by 0.8%. However, owing to [...]
XLS Merck Millipore | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 660.4 674.5 –2.1 Sales 656.5 668.7 –1.8 Operating result (EBIT) 87.0 72.3 20.3 Margin (% of sales) 13.3 10.8 EBITDA 163.7 151.5 8.1 Margin (% of sales) 24.9 22.7 EBITDA pre one-time items 169.7 161.9 4.8 Margin (% of sales) 25.8 24.2 Business free cash flow 54.4 81.1 –32.9 Development of total revenues and sales as well as results of operations The Merck Millipore division generated organic sales growth of 3.7% in the first quarter of 2014. This organic growth was countered by a negative foreign exchange impact of –5.5%, which primarily stemmed from the Japanese [...]
Overview – Q1 2014 Solid organic sales growth of around 4% outweighed by currency headwinds All divisions contribute to organic growth Profitability remains high – EBITDA pre one-time items up slightly to € 807 million despite substantial reduction in royalty, license and commission income as well as negative currency impact Earnings per share pre one-time items up 9.5% to € 2.31 Strong business free cash flow underscores financial strength High equity ratio as well as increased liquid funds reflect solid balance sheet structure XLS Merck Group | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 2,664.8 2,760.5 –3.5 Sales 2,613.9 [...]
XLS Performance Materials | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 402.7 422.1 –4.6 Sales 402.2 421.3 –4.5 Operating result (EBIT) 151.7 172.5 –12.1 Margin (% of sales) 37.7 41.0 EBITDA 178.8 203.3 –12.0 Margin (% of sales) 44.5 48.3 EBITDA pre one-time items 186.4 207.4 –10.1 Margin (% of sales) 46.3 49.2 Business free cash flow 165.5 199.0 –16.8 Development of total revenues and sales as well as results of operations In the first quarter of 2014, the Performance Materials division achieved a slight 1.1% organic increase in sales, despite a strong year-earlier quarter. Considerable currency headwinds of –5.6%, [...]
XLS Consumer Health | Key figures € million Q1 – 2014 Q1 – 2013* Change in % * The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 180.5 181.8 –0.7 Sales 180.2 181.7 –0.8 Operating result (EBIT) 36.7 36.8 – Margin (% of sales) 20.4 20.2 EBITDA 39.1 39.4 –0.8 Margin (% of sales) 21.7 21.7 EBITDA pre one-time items 41.3 39.3 5.0 Margin (% of sales) 22.9 21.6 Business free cash flow 16.2 20.8 –22.5 Development of total revenues and sales as well as results of operations In the first quarter of 2014, the Consumer Health division generated sales of € 180 million (Q1 2013: € 182 million). The [...]
